Sanara MedTech (SMTI)
(Delayed Data from NSDQ)
$34.68 USD
+1.17 (3.49%)
Updated Sep 12, 2024 04:00 PM ET
After-Market: $34.48 -0.20 (-0.58%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth F Momentum F VGM
Balance Sheet
Fiscal Year End for Sanara MedTech Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 5 | 9 | 19 | 0 | 7 |
Receivables | 9 | 7 | 3 | 2 | 1 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 5 | 4 | 2 | 1 | 1 |
Other Current Assets | 1 | 1 | 1 | 1 | 0 |
Total Current Assets | 19 | 21 | 25 | 4 | 9 |
Net Property & Equipment | 1 | 1 | 2 | 1 | 0 |
Investments & Advances | 3 | 3 | 5 | 1 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 49 | 35 | 5 | 3 | 1 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 74 | 61 | 36 | 10 | 11 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 2 | 1 | 1 | 0 | 0 |
Current Portion Long-Term Debt | 1 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 10 | 10 | 5 | 3 | 2 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 1 | 1 | 0 | 0 | 0 |
Total Current Liabilities | 14 | 13 | 6 | 4 | 3 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 2 |
Long-Term Debt | 9 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 5 | 6 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 29 | 19 | 6 | 4 | 5 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 11 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 73 | 65 | 46 | 13 | -2 |
Retained Earnings | -28 | -23 | -15 | -7 | -3 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 45 | 42 | 30 | 6 | 6 |
Total Liabilities & Shareholder's Equity | 74 | 61 | 36 | 10 | 11 |
Total Common Equity | 45 | 42 | 30 | 6 | -5 |
Shares Outstanding | 8.50 | 8.30 | 7.60 | 6.20 | 2.30 |
Book Value Per Share | 5.25 | 5.03 | 3.97 | 0.94 | -2.17 |
Fiscal Year End for Sanara MedTech Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 6 | 3 | 5 | 6 | 6 |
Receivables | 11 | 9 | 9 | 8 | 7 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 4 | 4 | 5 | 5 | 4 |
Other Current Assets | 0 | 1 | 1 | 1 | 0 |
Total Current Assets | 21 | 17 | 19 | 19 | 18 |
Net Property & Equipment | 1 | 1 | 1 | 1 | 1 |
Investments & Advances | 3 | 3 | 3 | 3 | 3 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 47 | 48 | 49 | 50 | 34 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 73 | 71 | 74 | 75 | 58 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 1 | 1 | 2 | 2 | 1 |
Current Portion Long-Term Debt | 0 | 1 | 1 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 9 | 9 | 10 | 10 | 8 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 1 | 1 | 1 | 1 | 1 |
Total Current Liabilities | 12 | 13 | 14 | 13 | 10 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 14 | 9 | 9 | 9 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 5 | 5 | 7 | 6 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 32 | 28 | 29 | 31 | 17 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 75 | 73 | 73 | 72 | 68 |
Retained Earnings | -33 | -30 | -28 | -28 | -27 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 41 | 43 | 45 | 44 | 41 |
Total Liabilities & Shareholder's Equity | 73 | 71 | 74 | 75 | 58 |
Total Common Equity | 41 | 43 | 45 | 44 | 41 |
Shares Outstanding | 8.60 | 8.60 | 8.50 | 8.50 | 8.30 |
Book Value Per Share | 4.81 | 5.00 | 5.25 | 5.19 | 4.93 |